转铁蛋白受体上调介导同型半胱氨酸诱导的脑内皮细胞细胞毒性作用
Transferrin receptor upregulation mediates homocysteine-induced cytotoxicity in cerebral endothelial cells
Jie Wang, Yaoqin Liu, Changyu Jiang, Dandan Wang, Jinhua Wang, Guangju Feng, Bin Zhong
Journal:BRAIN RESEARCH
IF:3.2
DOI:10.1016/j.brainres.2026.150486
PMID:
Published:2026-08-08
research field:伤口护理生物医学工程呼吸生物学纳米技术结构生物学材料科学生物化学
Abstract
Hyperhomocysteinemia (HHcy) is a recognized risk factor for cognitive impairment, including Alzheimer’s disease, but the mechanisms linking homocysteine (Hcy) accumulation to cerebral dysfunction remain unclear. Brain microvascular endothelial cells (BMECs) are an important cellular component of the blood–brain barrier (BBB) and play a key role in maintaining central nervous system homeostasis. However, how Hcy affects BMECs remains incompletely understood. In this study, we used the human brain microvascular endothelial cell line hCMEC/D3 to determine the half-maximal inhibitory concentration (IC 50 ) of Hcy by CCK-8 assay, and then performed transcriptomic analysis to identify Hcy-regulated genes associated with endothelial cell injury. Hcy reduced hCMEC/D3 cell viability in a dose-dependent manner, with an IC 50 of approximately 12.25 mM; therefore, 10 mM Hcy was selected for subsequent experiments. Transcriptomic sequencing revealed significant upregulation of the transferrin receptor ( Tfrc ) gene, which we confirmed by quantitative real-time PCR and Western blot analysis. Functionally, TFRC overexpression mimicked the Hcy-induced reduction in cell viability, whereas TFRC knockdown partially rescued cells from Hcy-induced cytotoxicity. TFRC overexpression reduced hCMEC/D3 cell viability, whereas TFRC knockdown partially alleviated Hcy-induced cytotoxicity. These results suggest that TFRC is involved in Hcy-induced injury of brain microvascular endothelial cells. Taken together, our in vitro findings provide a possible clue for future in vivo studies on HHcy-associated BBB dysfunction.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


